ZOLPIDEM TARTRATE IP/BP/USP/EP

img

What is Lorem Ipsum?

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

ZOLPIDEM TARTRATE IP/BP/USP/EP

✅ ZOLPIDEM TARTRATE (CAS 99294-93-6) – PRODUCT DESCRIPTION

Zolpidem Tartrate (CAS 99294-93-6) is a sedative-hypnotic medication used primarily in the treatment of insomnia. It works by binding to the GABA-A receptors in the brain, enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA), which leads to sedation and sleep onset. Zolpidem helps to improve sleep quality, reduce the time required to fall asleep, and minimize the number of times a person wakes up during the night. This medication is typically prescribed for the short-term management of insomnia and is commonly used in cases where sleep disturbances are causing significant daytime impairment. This white to off-white crystalline powder is available in pharmaceutical grades (IP/BP/USP), ensuring high purity for use in oral tablets, sublingual tablets, and oral solutions. We supply Zolpidem Tartrate to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

  • Pharmaceuticals (treatment of insomnia, sleep disorders, and sleep disturbances)

  • Healthcare (used for improving sleep initiation and sleep maintenance)

  • Research (studies on sedative-hypnotic medications, GABA receptor modulation, and sleep cycle regulation)

  • Manufacturing (production of oral tablets, sublingual tablets, and oral solutions for sleep disorders)

🧪 Available Grades:

  • Pharmaceutical Grade (IP/BP/USP)

  • Reagent Grade

  • Laboratory Grade

⚙️ Functions:

  • Sedative-hypnotic medication used to treat insomnia and sleep disorders

  • Enhances GABA receptor activity to promote sleep onset and reduce nighttime wakefulness

  • Used for short-term management of sleep disturbances and difficulties falling asleep

  • Reagent in sleep disorder studies, GABA receptor research, and neuropharmacology research

  • Effective in treating acute insomnia, sleep onset difficulty, and sleep maintenance issues

🧩 Classified Under:

 

  • Pharmaceuticals

  • Sedative-Hypnotic Medications

  • Insomnia Treatments

  • Active Pharmaceutical Ingredients (APIs)

  • Central Nervous System Agents

CAS Number

99294-93-6

Formula

C19H21N3O3·C4H6O6

Molecular Weight

764.89 g/mol

Density

1.25 g/cm³

Gravity

~1.25

Melting Point

~172-175°C

Partical Size

White to off-white crystalline powder
Get Quote